Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Huntington Disease × Docosahexaenoic Acids × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Polyps 1 Melanoma 1 Lymphoma, Follicular 1 Huntington Disease 1 Carcinoma, Non-Small-Cell Lung 1 Adenomatous Polyposis Coli 1

Interventions

eicosapentaenoic acid ethyl ester 1 Docosahexaenoic Acids 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00146211 2007-12-27

TREND-HD - A Trial of Ethyl-EPA (Miraxion™) in Treating Mild to Moderate Huntington's Disease

Amarin Neuroscience Ltd

Phase 3 Completed

Huntington Disease, Lymphoma, Follicular

Data powered by HemOnc (CC BY 4.0) Colophon ⚡